The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy
Open accessAbstract
Advances in bioinformatics, genomics, proteomics, and metabolomics have facilitated the development of novel anticancer agents that have decreased side effects and increased safety. Theranostics, systems that have combined therapeutic effects and diagnostic capabilities, have garnered increasing attention recently because of their potential use in personalized medicine, including cancer‐targeting treatments for patients. One interesting approach to achieving this potential involves the development of cancer‐associated, stimuli‐driven, turn on theranostics. Multicomponent constructs of this type would have the capability of selectively delivering therapeutic reagents into cancer cells or tumor tissues while simultaneously generating unique signals that can be readily monitored under both in vitro and in vivo conditions. Specifically, their combined anticancer activities and selective visual signal respond to cancer‐associated stimuli, would make these theranostic agents more highly efficient and specific for cancer treatment and diagnosis. This article focuses on the progress of stimuli‐responsive turn on theranostics that activate diagnostic signals and release therapeutic reagents in response to the cancer‐associated stimuli. The present article not only provides the fundamental backgrounds of diagnostic and therapeutic tools that have been widely utilized for developing theranostic agents, but also discusses the current approaches for developing stimuli‐responsive turn on theranostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Hydrotalcite-type anionic clays: Preparation, properties and applications.
Cavani, F., Trifirò, F., & Vaccari, A. (1991) · Catalysis Today · doi:10.1016/0920-5861(91)80068-k · Cited by 5,980
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Self-citationInnovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Self-citationSupramolecular photosensitizers rejuvenate photodynamic therapy
Li, X., Lee, S., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00594f · Cited by 1,114
Self-citationDesign of superior phototheranostic agents guided by Jablonski diagrams
Feng, G., Zhang, G.-Q., & Ding, D. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00671h · Cited by 783
Liu, G., Zou, J., Tang, Q., Yang, X., Zhang, Y., Zhang, Q., Huang, W., Chen, P., Shao, J., & Dong, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b13421 · Cited by 691
Supramolecular Antibacterial Materials for Combatting Antibiotic Resistance
Li, X., Bai, H., Yang, Y., Yoon, J., Wang, S., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201805092 · Cited by 542
Self-citationPhthalocyanines as medicinal photosensitizers: Developments in the last five years
Li, X., Zheng, B.-D., Peng, X.-H., Li, S.-Z., Ying, J.-W., Zhao, Y., Huang, J.-D., & Yoon, J. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.08.003 · Cited by 523
Self-citationUltrasound‐Activated Sensitizers and Applications
Lin, X., Song, J., Chen, X., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201906823 · Cited by 501
Self-citationAggregation‐enhanced theranostics: AIE sparkles in biomedical field
Kang, M., Zhang, Z., Song, N., Li, M., Sun, P., Chen, X., Wang, D., & Tang, B. Z. (2020) · Aggregate · doi:10.1002/agt2.7 · Cited by 485
Self-citationDisulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
Sun, B., Luo, C., Yu, H., Zhang, X., Chen, Q., Yang, W., Wang, M., Kan, Q., Zhang, H., Wang, Y., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00737 · Cited by 426
Li, X., Lee, D., Huang, J., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806551 · Cited by 426
Self-citationBhatia, S. N., Chen, X., Dobrovolskaia, M. A., & Lammers, T. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00496-9 · Cited by 406
Self-citationDevelopment of endogenous enzyme-responsive nanomaterials for theranostics
Mu, J., Lin, J., Huang, P., & Chen, X. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00663b · Cited by 393
Self-citationThe fast-growing field of photo-driven theranostics based on aggregation-induced emission
Zhang, Z., Kang, M., Tan, H., Song, N., Li, M., Xiao, P., Yan, D., Zhang, L., Wang, D., & Tang, B. Z. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01138c · Cited by 374
Wang, Q., Dai, Y., Xu, J., Cai, J., Niu, X., Zhang, L., Chen, R., Shen, Q., Huang, W., & Fan, Q. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901480 · Cited by 369
Wang, D., Lee, M. M. S., Shan, G., Kwok, R. T. K., Lam, J. W. Y., Su, H., Cai, Y., & Tang, B. Z. (2018) · Advanced Materials · doi:10.1002/adma.201802105 · Cited by 365
Li, X., Kim, C.-Y., Lee, S., Lee, D., Chung, H.-M., Kim, G., Heo, S.-H., Kim, C., Hong, K.-S., & Yoon, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05916 · Cited by 343
Self-citationAggregation-Induced Emission: A Trailblazing Journey to the Field of Biomedicine
Zhu, C., Kwok, R. T. K., Lam, J. W. Y., & Tang, B. Z. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00600 · Cited by 343
Chen, C., Ou, H., Liu, R., & Ding, D. (2020) · Advanced Materials · doi:10.1002/adma.201806331 · Cited by 343
Graphene‐Based Smart Platforms for Combined Cancer Therapy
Gu, Z., Zhu, S., Yan, L., Zhao, F., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201800662 · Cited by 334
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
Sun, B., Luo, C., Zhang, X., Guo, M., Sun, M., Yu, H., Chen, Q., Yang, W., Wang, M., Zuo, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11193-x · Cited by 319
Recent Progress in External‐Stimulus‐Responsive 2D Covalent Organic Frameworks
She, P., Qin, Y., Wang, X., & Zhang, Q. (2022) · Advanced Materials · doi:10.1002/adma.202101175 · Cited by 305
Organelle-Targeted Photosensitizers for Precision Photodynamic Therapy
Wang, R., Li, X., & Yoon, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c02019 · Cited by 293
Self-citationA Supramolecular Radical Dimer: High‐Efficiency NIR‐II Photothermal Conversion and Therapy
Tang, B., Li, W., Chang, Y., Yuan, B., Wu, Y., Zhang, M., Xu, J., Li, J., & Zhang, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910257 · Cited by 276
Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy
Fu, S., Li, G., Zang, W., Zhou, X., Shi, K., & Zhai, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.012 · Cited by 266
Qi, J., Sun, C., Li, D., Zhang, H., Yu, W., Zebibula, A., Lam, J. W. Y., Xi, W., Zhu, L., Cai, F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02452 · Cited by 226
Li, Q., Li, Y., Min, T., Gong, J., Du, L., Phillips, D. L., Liu, J., Lam, J. W. Y., Sung, H. H. Y., Williams, I. D., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201909706 · Cited by 211
Li, D., Deng, X., Xu, Z., Wang, D., Xu, G., Zhang, P., Qiu, P., Xie, W., Wang, D., Tang, B. Z., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202303967 · Cited by 63
Yang, M., Ou, X., Zhang, J., Sun, J., Kwok, R. T. K., Lam, J. W. Y., Fan, J., & Tang, B. Z. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202411838 · Cited by 42
Nanoparticle Activation Methods in Cancer Treatment
White, B. D., Duan, C., & Townley, H. E. (2019) · Biomolecules · doi:10.3390/biom9050202 · Cited by 32
Metadata
- Authors
- Li, X., Kim, J., Yoon, J., & Chen, X.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2017-03-29
- Volume
- 29
- Issue
- 23
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2602000459
- Cited by
- 362
- References
- 211
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.